KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 129 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,552,920 | +22.1% | 536,429 | -6.7% | 0.23% | +23.4% |
| Q1 2023 | $6,186,354 | -18.1% | 574,940 | +14.0% | 0.19% | -18.6% |
| Q4 2022 | $7,552,811 | +6.5% | 504,193 | -8.7% | 0.23% | -0.4% |
| Q3 2022 | $7,092,000 | +74.3% | 552,350 | +31.5% | 0.23% | +66.9% |
| Q2 2022 | $4,070,000 | -44.8% | 419,995 | -43.4% | 0.14% | -24.0% |
| Q1 2022 | $7,377,000 | +4.5% | 742,158 | +23.8% | 0.18% | +26.2% |
| Q4 2021 | $7,056,000 | +52.7% | 599,522 | +47.7% | 0.14% | +64.8% |
| Q3 2021 | $4,622,000 | – | 405,834 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 3,378,164 | $47,564,549 | 2.03% |
| Fairmount Funds Management LLC | 704,459 | $9,918,783 | 1.40% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $8,448,000 | 1.24% |
| AlphaCentric Advisors LLC | 110,000 | $1,548,800 | 0.86% |
| Lion Point Capital, LP | 130,691 | $1,840,129 | 0.83% |
| Soleus Capital Management, L.P. | 519,640 | $7,316,531 | 0.81% |
| Parkman Healthcare Partners LLC | 291,703 | $4,107,178 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 660,124 | $9,294,546 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 188,298 | $2,651,236 | 0.37% |
| Jackson Creek Investment Advisors LLC | 65,654 | $924 | 0.37% |